APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Contract Sales Organization (CSO)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pharmaceutical Contract Sales Organization (CSO) Industry Growth and Trends Forecast to 2032

16 January 2026113 pages

Choose your research edition.

Industry ResearchPharmaceutical Contract Sales Organization (CSO) Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Contract Sales Organization (CSO) Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Contract Sales Organization (CSO) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Contract Sales Organization (CSO) Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Contract Sales Organization (CSO) Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

According to APO Research, the global Pharmaceutical Contract Sales Organization (CSO) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pharmaceutical Contract Sales Organization (CSO) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Contract Sales Organization (CSO) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Contract Sales Organization (CSO) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Pharmaceutical Contract Sales Organization (CSO) market include China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, Ashfield Engage (Inizio), Amplity Health, Sinco Pharma, Syneos Health and EPS Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pharmaceutical Contract Sales Organization (CSO) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharmaceutical Contract Sales Organization (CSO) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical Contract Sales Organization (CSO) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical Contract Sales Organization (CSO).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Pharmaceutical Contract Sales Organization (CSO) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharmaceutical Contract Sales Organization (CSO) Market by Company

China Medical System (CMS)

IQVIA

PHOENIX Group

EVERSANA

Ashfield Engage (Inizio)

Amplity Health

Sinco Pharma

Syneos Health

EPS Corporation

Uniphar Group

CMIC Group

SciClone Pharmaceuticals

China Pioneer Pharma

Promoveo Health

CSO Pharmitalia

GTS Solution

QFR Solutions

Pharmaceutical Contract Sales Organization (CSO) Segment by Type

Personal Promotion

Non-Personal Promotion

Others

Pharmaceutical Contract Sales Organization (CSO) Segment by Application

Pharmaceutical Company

Biotechnology Company

Generic Company

Others

Pharmaceutical Contract Sales Organization (CSO) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Contract Sales Organization (CSO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Contract Sales Organization (CSO) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Contract Sales Organization (CSO).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Pharmaceutical Contract Sales Organization (CSO) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Contract Sales Organization (CSO) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Pharmaceutical Contract Sales Organization (CSO) Market Share by Region (2021-2026) Table 4. Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Pharmaceutical Contract Sales Organization (CSO) Market Share by Region (2027-2032) Table 6. Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Pharmaceutical Contract Sales Organization (CSO) Market Size Share by Type (2021-2026) Table 9. Global Pharmaceutical Contract Sales Organization (CSO) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Pharmaceutical Contract Sales Organization (CSO) Market Size Share Forecasted by Type (2027-2032) Table 11. North America Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Pharmaceutical Contract Sales Organization (CSO) Market Size Share by Application (2021-2026) Table 24. Global Pharmaceutical Contract Sales Organization (CSO) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Pharmaceutical Contract Sales Organization (CSO) Market Size Share Forecasted by Application (2027-2032) Table 26. North America Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Pharmaceutical Contract Sales Organization (CSO) Industry Trends Table 37. Pharmaceutical Contract Sales Organization (CSO) Industry Drivers Table 38. Pharmaceutical Contract Sales Organization (CSO) Industry Opportunities and Challenges Table 39. Pharmaceutical Contract Sales Organization (CSO) Industry Restraints Table 40. Global Pharmaceutical Contract Sales Organization (CSO) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Pharmaceutical Contract Sales Organization (CSO) Revenue Market Share by Company (2021-2026) Table 42. Global Pharmaceutical Contract Sales Organization (CSO) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Pharmaceutical Contract Sales Organization (CSO) Key Company Headquarters & Area Served Table 44. Global Pharmaceutical Contract Sales Organization (CSO) Company, Product Type & Application Table 45. Global Pharmaceutical Contract Sales Organization (CSO) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Pharmaceutical Contract Sales Organization (CSO) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. China Medical System (CMS) Company Information Table 49. China Medical System (CMS) Business Overview Table 50. China Medical System (CMS) Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. China Medical System (CMS) Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 52. China Medical System (CMS) Recent Development Table 53. IQVIA Company Information Table 54. IQVIA Business Overview Table 55. IQVIA Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. IQVIA Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 57. IQVIA Recent Development Table 58. PHOENIX Group Company Information Table 59. PHOENIX Group Business Overview Table 60. PHOENIX Group Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. PHOENIX Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 62. PHOENIX Group Recent Development Table 63. EVERSANA Company Information Table 64. EVERSANA Business Overview Table 65. EVERSANA Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. EVERSANA Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 67. EVERSANA Recent Development Table 68. Ashfield Engage (Inizio) Company Information Table 69. Ashfield Engage (Inizio) Business Overview Table 70. Ashfield Engage (Inizio) Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Ashfield Engage (Inizio) Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 72. Ashfield Engage (Inizio) Recent Development Table 73. Amplity Health Company Information Table 74. Amplity Health Business Overview Table 75. Amplity Health Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Amplity Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 77. Amplity Health Recent Development Table 78. Sinco Pharma Company Information Table 79. Sinco Pharma Business Overview Table 80. Sinco Pharma Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Sinco Pharma Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 82. Sinco Pharma Recent Development Table 83. Syneos Health Company Information Table 84. Syneos Health Business Overview Table 85. Syneos Health Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Syneos Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 87. Syneos Health Recent Development Table 88. EPS Corporation Company Information Table 89. EPS Corporation Business Overview Table 90. EPS Corporation Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. EPS Corporation Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 92. EPS Corporation Recent Development Table 93. Uniphar Group Company Information Table 94. Uniphar Group Business Overview Table 95. Uniphar Group Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Uniphar Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 97. Uniphar Group Recent Development Table 98. CMIC Group Company Information Table 99. CMIC Group Business Overview Table 100. CMIC Group Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. CMIC Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 102. CMIC Group Recent Development Table 103. SciClone Pharmaceuticals Company Information Table 104. SciClone Pharmaceuticals Business Overview Table 105. SciClone Pharmaceuticals Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. SciClone Pharmaceuticals Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 107. SciClone Pharmaceuticals Recent Development Table 108. China Pioneer Pharma Company Information Table 109. China Pioneer Pharma Business Overview Table 110. China Pioneer Pharma Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. China Pioneer Pharma Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 112. China Pioneer Pharma Recent Development Table 113. Promoveo Health Company Information Table 114. Promoveo Health Business Overview Table 115. Promoveo Health Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Promoveo Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 117. Promoveo Health Recent Development Table 118. CSO Pharmitalia Company Information Table 119. CSO Pharmitalia Business Overview Table 120. CSO Pharmitalia Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. CSO Pharmitalia Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 122. CSO Pharmitalia Recent Development Table 123. GTS Solution Company Information Table 124. GTS Solution Business Overview Table 125. GTS Solution Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. GTS Solution Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 127. GTS Solution Recent Development Table 128. QFR Solutions Company Information Table 129. QFR Solutions Business Overview Table 130. QFR Solutions Pharmaceutical Contract Sales Organization (CSO) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. QFR Solutions Pharmaceutical Contract Sales Organization (CSO) Product Portfolio Table 132. QFR Solutions Recent Development Table 133. North America Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Pharmaceutical Contract Sales Organization (CSO) Market Share by Country (2021-2026) Table 136. North America Pharmaceutical Contract Sales Organization (CSO) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Pharmaceutical Contract Sales Organization (CSO) Market Share Forecast by Country (2027-2032) Table 138. Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Pharmaceutical Contract Sales Organization (CSO) Market Share by Country (2021-2026) Table 141. Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Pharmaceutical Contract Sales Organization (CSO) Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Share by Country (2021-2026) Table 146. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Share Forecast by Country (2027-2032) Table 148. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Share by Country (2021-2026) Table 151. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Share by Country (2021-2026) Table 156. Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Pharmaceutical Contract Sales Organization (CSO) Product Image Figure 3. Global Pharmaceutical Contract Sales Organization (CSO) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Pharmaceutical Contract Sales Organization (CSO) Market Size (2021-2032) & (US$ Million) Figure 5. Global Pharmaceutical Contract Sales Organization (CSO) Market Share by Region: 2025 VS 2032 Figure 6. Global Pharmaceutical Contract Sales Organization (CSO) Market Share by Region (2021-2032) Figure 7. North America Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Personal Promotion Image Figure 13. Global Personal Promotion Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Non-Personal Promotion Image Figure 15. Global Non-Personal Promotion Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Pharmaceutical Contract Sales Organization (CSO) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Pharmaceutical Contract Sales Organization (CSO) Market Share by Type 2025 VS 2032 Figure 20. North America Pharmaceutical Contract Sales Organization (CSO) Market Size Share by Type (2021-2032) Figure 21. Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Share by Type (2021-2032) Figure 23. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Share by Type (2021-2032) Figure 25. Pharmaceutical Company Image Figure 26. Global Pharmaceutical Company Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Biotechnology Company Image Figure 28. Global Biotechnology Company Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Generic Company Image Figure 30. Global Generic Company Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Pharmaceutical Contract Sales Organization (CSO) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Pharmaceutical Contract Sales Organization (CSO) Market Share by Application 2025 VS 2032 Figure 35. North America Pharmaceutical Contract Sales Organization (CSO) Market Size Share by Application (2021-2032) Figure 36. Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Share by Application (2021-2032) Figure 38. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Pharmaceutical Contract Sales Organization (CSO) Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Pharmaceutical Contract Sales Organization (CSO) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Pharmaceutical Contract Sales Organization (CSO) Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Pharmaceutical Contract Sales Organization (CSO) Market Share by Country (2021-2032) Figure 45. Europe Pharmaceutical Contract Sales Organization (CSO) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Pharmaceutical Contract Sales Organization (CSO) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pharmaceutical Contract Sales Organization (CSO) Market Share by Country (2021-2032) Figure 48. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Share by Country (2021-2032) Figure 51. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pharmaceutical Contract Sales Organization (CSO) Market Share by Country (2021-2032) Figure 54. Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Personal Promotion
  • Non-Personal Promotion
  • Others
Applications
  • Pharmaceutical Company
  • Biotechnology Company
  • Generic Company
  • Others
Companies covered
  • China Medical System (CMS)
  • IQVIA
  • PHOENIX Group
  • EVERSANA
  • Ashfield Engage (Inizio)
  • Amplity Health
  • Sinco Pharma
  • Syneos Health
  • EPS Corporation
  • Uniphar Group
  • CMIC Group
  • SciClone Pharmaceuticals
  • China Pioneer Pharma
  • Promoveo Health
  • CSO Pharmitalia
  • GTS Solution
  • QFR Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Pharmaceutical Contract Sales Organization (CSO) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Region (2021-2032)
  5. 1.4.1 Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Region (2021-2026)
  6. 1.4.2 Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Region (2027-2032)
  7. 1.5 Key Regions Pharmaceutical Contract Sales Organization (CSO) Market Size (2021-2032)
  8. 1.5.1 North America Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (2021-2032)
2 Pharmaceutical Contract Sales Organization (CSO) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Personal Promotion
  3. 2.1.2 Non-Personal Promotion
  4. 2.1.3 Others
  5. 2.2 Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Type
  6. 2.2.1 Global Pharmaceutical Contract Sales Organization (CSO) Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Pharmaceutical Contract Sales Organization (CSO) Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Pharmaceutical Contract Sales Organization (CSO) Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Regions
  10. 2.3.1 North America Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Type (2021-2026)
3 Pharmaceutical Contract Sales Organization (CSO) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical Company
  3. 3.1.2 Biotechnology Company
  4. 3.1.3 Generic Company
  5. 3.1.4 Others
  6. 3.2 Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Application
  7. 3.2.1 Global Pharmaceutical Contract Sales Organization (CSO) Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Pharmaceutical Contract Sales Organization (CSO) Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Pharmaceutical Contract Sales Organization (CSO) Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Regions
  11. 3.3.1 North America Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Pharmaceutical Contract Sales Organization (CSO) Industry Trends
  2. 4.2 Pharmaceutical Contract Sales Organization (CSO) Industry Drivers
  3. 4.3 Pharmaceutical Contract Sales Organization (CSO) Industry Opportunities and Challenges
  4. 4.4 Pharmaceutical Contract Sales Organization (CSO) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Pharmaceutical Contract Sales Organization (CSO) Revenue (2021-2026)
  2. 5.2 Global Pharmaceutical Contract Sales Organization (CSO) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Pharmaceutical Contract Sales Organization (CSO) Key Company Headquarters & Area Served
  4. 5.4 Global Pharmaceutical Contract Sales Organization (CSO) Company, Product Type & Application
  5. 5.5 Global Pharmaceutical Contract Sales Organization (CSO) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Pharmaceutical Contract Sales Organization (CSO) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Pharmaceutical Contract Sales Organization (CSO) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Pharmaceutical Contract Sales Organization (CSO) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 China Medical System (CMS)
  2. 6.1.1 China Medical System (CMS) Company Information
  3. 6.1.2 China Medical System (CMS) Business Overview
  4. 6.1.3 China Medical System (CMS) Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 China Medical System (CMS) Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  6. 6.1.5 China Medical System (CMS) Recent Developments
  7. 6.2 IQVIA
  8. 6.2.1 IQVIA Company Information
  9. 6.2.2 IQVIA Business Overview
  10. 6.2.3 IQVIA Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 IQVIA Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  12. 6.2.5 IQVIA Recent Developments
  13. 6.3 PHOENIX Group
  14. 6.3.1 PHOENIX Group Company Information
  15. 6.3.2 PHOENIX Group Business Overview
  16. 6.3.3 PHOENIX Group Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 PHOENIX Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  18. 6.3.5 PHOENIX Group Recent Developments
  19. 6.4 EVERSANA
  20. 6.4.1 EVERSANA Company Information
  21. 6.4.2 EVERSANA Business Overview
  22. 6.4.3 EVERSANA Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 EVERSANA Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  24. 6.4.5 EVERSANA Recent Developments
  25. 6.5 Ashfield Engage (Inizio)
  26. 6.5.1 Ashfield Engage (Inizio) Company Information
  27. 6.5.2 Ashfield Engage (Inizio) Business Overview
  28. 6.5.3 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  30. 6.5.5 Ashfield Engage (Inizio) Recent Developments
  31. 6.6 Amplity Health
  32. 6.6.1 Amplity Health Company Information
  33. 6.6.2 Amplity Health Business Overview
  34. 6.6.3 Amplity Health Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Amplity Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  36. 6.6.5 Amplity Health Recent Developments
  37. 6.7 Sinco Pharma
  38. 6.7.1 Sinco Pharma Company Information
  39. 6.7.2 Sinco Pharma Business Overview
  40. 6.7.3 Sinco Pharma Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Sinco Pharma Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  42. 6.7.5 Sinco Pharma Recent Developments
  43. 6.8 Syneos Health
  44. 6.8.1 Syneos Health Company Information
  45. 6.8.2 Syneos Health Business Overview
  46. 6.8.3 Syneos Health Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Syneos Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  48. 6.8.5 Syneos Health Recent Developments
  49. 6.9 EPS Corporation
  50. 6.9.1 EPS Corporation Company Information
  51. 6.9.2 EPS Corporation Business Overview
  52. 6.9.3 EPS Corporation Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 EPS Corporation Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  54. 6.9.5 EPS Corporation Recent Developments
  55. 6.10 Uniphar Group
  56. 6.10.1 Uniphar Group Company Information
  57. 6.10.2 Uniphar Group Business Overview
  58. 6.10.3 Uniphar Group Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Uniphar Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  60. 6.10.5 Uniphar Group Recent Developments
  61. 6.11 CMIC Group
  62. 6.11.1 CMIC Group Company Information
  63. 6.11.2 CMIC Group Business Overview
  64. 6.11.3 CMIC Group Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 CMIC Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  66. 6.11.5 CMIC Group Recent Developments
  67. 6.12 SciClone Pharmaceuticals
  68. 6.12.1 SciClone Pharmaceuticals Company Information
  69. 6.12.2 SciClone Pharmaceuticals Business Overview
  70. 6.12.3 SciClone Pharmaceuticals Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 SciClone Pharmaceuticals Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  72. 6.12.5 SciClone Pharmaceuticals Recent Developments
  73. 6.13 China Pioneer Pharma
  74. 6.13.1 China Pioneer Pharma Company Information
  75. 6.13.2 China Pioneer Pharma Business Overview
  76. 6.13.3 China Pioneer Pharma Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 China Pioneer Pharma Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  78. 6.13.5 China Pioneer Pharma Recent Developments
  79. 6.14 Promoveo Health
  80. 6.14.1 Promoveo Health Company Information
  81. 6.14.2 Promoveo Health Business Overview
  82. 6.14.3 Promoveo Health Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Promoveo Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  84. 6.14.5 Promoveo Health Recent Developments
  85. 6.15 CSO Pharmitalia
  86. 6.15.1 CSO Pharmitalia Company Information
  87. 6.15.2 CSO Pharmitalia Business Overview
  88. 6.15.3 CSO Pharmitalia Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 CSO Pharmitalia Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  90. 6.15.5 CSO Pharmitalia Recent Developments
  91. 6.16 GTS Solution
  92. 6.16.1 GTS Solution Company Information
  93. 6.16.2 GTS Solution Business Overview
  94. 6.16.3 GTS Solution Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 GTS Solution Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  96. 6.16.5 GTS Solution Recent Developments
  97. 6.17 QFR Solutions
  98. 6.17.1 QFR Solutions Company Information
  99. 6.17.2 QFR Solutions Business Overview
  100. 6.17.3 QFR Solutions Pharmaceutical Contract Sales Organization (CSO) Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 QFR Solutions Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
  102. 6.17.5 QFR Solutions Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026)
  3. 7.3 North America Pharmaceutical Contract Sales Organization (CSO) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026)
  3. 8.3 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026)
  3. 10.3 South America Pharmaceutical Contract Sales Organization (CSO) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst